COMPARATIVE STUDY OF HYPOGLYCEMIC EFFECTS AND ANTIOXIDANT POTENTIAL OF POLYHERBAL FORMULATION IN ALLOXAN INDUCED DIABETIC RATS AN ALTERNATIVE THERAPEUTIC AGENT FOR DIABETES MANAGEMENT
HTML Full TextCOMPARATIVE STUDY OF HYPOGLYCEMIC EFFECTS AND ANTIOXIDANT POTENTIAL OF POLYHERBAL FORMULATION IN ALLOXAN INDUCED DIABETIC RATS AN ALTERNATIVE THERAPEUTIC AGENT FOR DIABETES MANAGEMENT
Syeda Shahana *1, Syeda Shabana 1, Ghalib Hundekari 1, Mohd Saifuddin 1, A.G. Nikalje 2 and Shaikh Abdulla Yousuf 1
Kamala Nehru Polytechnic Pharmacy 1, Aurangabad, Maharashtra, India.
Y.B. Chavan College of Pharmacy 2, Aurangabad, Maharashtra, India
ABSTRACT: Objective: Comparative screening of Polyherbal preparations for anti-diabetic and antioxidant activity in rats. Materials and Methods: The blood glucose lowering activity of the Polyherbal preparation 1and 2 was studied in normal rats and alloxan-induced diabetic rats after oral administration at doses of 1.0 ml/kg body wt. Blood samples were collected from the tail vein method on 1,7, 15, and 23rd day. Biochemical parameters like SGOT, SGPT, Liver Glycogen, Urea, Creatinine, LDL, Cholesterol etc were evaluated. Effect was also observed on antioxidant activity and learning and memory dysfunction in diabetes. The data was compared statistically using the one-way ANOVA method followed by the Dunnett test. Results: The Polyherbal preparation 1and 2 produced significant (P<0.05,0.01) reduction in the blood glucose level and other biochemical parameters in diabetic rats after 23 days of study compared with that of control and Metformin. They also have significant antioxidant activity effective in diabetic neuropathy and learning and memory dysfunction. Conclusion: The Polyherbal preparation 1 and 2 showed antidiabetic in diabetic rats. This preparation can be used as an alternative to anti-diabetic preparation. However, it requires further extensive molecular level studies for identifying mechanism of actions.
Keywords: |
Antidiabetic, Polyherbal,
Alloxan, Antioxidant, Metformin
INTRODUCTION: Diabetes Mellitus consists of a group of disorders characterized by hyperglycemia, altered metabolism of lipids, carbohydrates, and proteins and an increased risk of complications from vascular disease.
The metabolic consequences of prolonged hyperglycemia and dyslipidemia, including accelerated atherosclerosis, chronic kidney disease, and blindness, pose an enormous burden on patients with DM and on society. Improvements in our understanding of the pathogenesis of diabetes and its complications and in the prevention and therapy of diabetes are critical to meeting this challenge 1. Herbal formulations have been used by the majority of Indians since ancient times.
In recent years, there has been an increased inclination towards the herbal formulations due to the trend towards the natural sources and a healthy life style. Moreover, the complexity, side effects and costly treatment associated with the allopathic medicines have caused both the health care practitioners and the majority of world populations to turn towards alternative therapies, more likely towards the herbal medicines 2.
Most of the hypoglycemic agents and hypolipidemics used in allopathic practice to treat diabetes mellitus and hyperlipidemia are reported to have side effects in long term use 3. Hence, there is the need to search for effective and safe drugs for these ailments. Neuropathy is the major reason for morbidity and mortality among diabetic patients. Oxidative stress has been suggested as a major contributor to the diabetic neuropathy.
Increased production of reactive oxygen species and decreased antioxidant defense in diabetic neuropathy has been reported. Metabolic diseases such as diabetes and obesity have been associated with increased vulnerability to stress 4 and cognitive dysfunction 5. Diabetes mellitus can lead to functional and structural deficits in both the peripheral and central nervous system. The pathogenesis of these deficits is multifactor and may involve microvascular dysfunction and oxidative stress 6.
Drug:
Polyherbal:
Ingredients: Syzygium cumini, Inula racemosa, Ricinus Communis, Boerhavia diffusa, Zingiber Officinale, Acorus calamus, Askand, Asparagus racemosus, Symplocos racemosa, Woodfordia fruticosa etc.
Drug:
Polyherbal:
Ingredients: Syzygium cumini, Momordica charantia, Punica Granatum, Gymnema sylvestre, Withania somnifera, Asphaltum, Chlorophytum Borivilianum, Allium sativum, Piper longum, Emblic Myrobalan, Aloe barbadensis etc.
MATERIALS AND METHODS:
Collection of Drugs:
The polyherbal preparations 1 and 2 were purchased from the local market.
Dose and route of administration:
List of chemicals along with their doses and route of administration
S. no. | Chemical | Dose | Route |
1. | Alloxan | 150 mg/kg | Intraperitoneal |
2. | Glucose | 5% | Oral |
3. | Metformin | 120 mg/kg | Oral |
4. | Polyherbal 1 | 1ml/kg | Oral |
5. | Polyherbal 2 | 1ml/kg | Oral |
Volume of administration:
The volume of administration (Oral and i.p.) was calculated based on the route of administration and body weight of animals and was kept constant.
Storage condition:
All the drugs and solutions were prepared freshly and used on the day of dosing. The solutions were stored, if required, in airtight amber coloured vials in the refrigerator. Swiss albino rats weighing between (125-200gm) were used. They were maintained at temp of 25 ± 2˚C and relative humidity of 45 to 55% and under standard environmental conditions (12 h. light /12 h. dark cycles). The animals had free access to food and water. Animals were obtained from Aurangabad, Maharashtra, India. All the experiments were carried out between 9 to 18 hrs. The experimental protocol was approved by Institutional Animal Ethics Committee (IAEC) of Y. B. Chavan College of Pharmacy, Dr Rafiq Zakaria Campus, Aurangabad. (Approval number- CPCSEA/IEAC/P’col-18/2011-12/42). The animals were randomly divided into five groups, each group contained six animals.
Daily acclimatization of animals:
The animals were shifted from animal house to the laboratory one hour prior to the experiment. The respective apparatus were cleaned with ethanol and damp cloth wherever necessary to avoid possible bias due to odour left by the previous used animal.
Induction of Experimental diabetes:
Overnight fasted experimental rats from groups 2, 3, 4, 5 were injected with Alloxan (Sigma, USA) at a dose of 150 mg/kg body weight 7. The chemical was injected intraperitoneally (i.p) within 10 min after dissolving in distilled water. The rats in group 1 were injected with distilled water as a vehicle control. The animals were allowed to drink 5% glucose solution overnight to overcome the drug induced hypoglycemia. Fasting blood glucose (FBG) was estimated at the time of induction of diabetes and postprandial glucose (PPG) was checked regularly until stable hyperglycemia was achieved. After a week time for the development of diabetes, the rats with moderate diabetes having glycosuria and hyperglycemia (blood glucose levels of 250 mg/dl) were included in the study as stable hyperglycemic animals. Once the stable hyperglycemia was achieved, the rats belonging to group 5 were treated with an oral dose of metformin (120 mg/kg bw), Group 4 with Polyherbal 2 (1ml/kg), Group 3 with Polyherbal 1(1ml/kg), once every day for 15 consecutive days while groups 1 and 2 rats received only Distilled water (as vehicle control).
RESULTS:
As shown in Tables 2, 3, 4 and 5 there was significant reduction in blood glucose, other biochemical parameters and also diabetic neuropathy and learning and memory dysfunction. As shown Fig. 1-7.
TABLE: 1 GROUPS AND TREATMENT
Groups | Treatment | Dose |
1 | Normal control | Distilled water |
2 | Diabetic control | Distilled water |
3 | Polyherbal 1 | 1 ml/kg |
4 | Polyherbal 2 | 1ml/kg |
5 | Metformin (Standard) | 120 mg/kg |
After 15 days of treatment with Polyherbal 1 and 2 all the tests for diabetic neuropathy and for learning and memory dysfunction were carried out and the results obtained are given below
Blood Glucose:
TABLE 2: EFFECT OF POLYHERBAL 1 AND POLYHERBAL 2 ON FASTING BLOOD GLUCOSE.
Animal: Rats Alloxan: 150mg/kg, i.p.
Group | Treatment | Fasting blood glucose level (mg/dl) | |||
Initial | 1st week | 2nd week | 3rd week | ||
1 | Normal Control | 127.6±3.6 | 126.8±3.3 | 128.8±2.5 | 129.8±3.4 |
2 | Diabetic control | 132.6±5.5 | 325±15.5 | 309±8.4 | 309.6±7.7 |
3 | Diabetic + Polyherbal 1 (1ml/kg) | 122.8±2.3* | 287±8.5** | 155.5±3.4** | 139.6±3.7* |
4 | Diabetic +Polyherbal 2 (1ml/kg) | 132.6±5.2* | 306.1±3.7** | 175.5±3.2** | 156.8±5.4** |
5 | Diabetic + Metformin (120mg/kg) | 132.±4.7* | 305.5±6.5** | 163.8±4.5** | 153±3.7* |
Results are expressed as Mean ± SEM (n=6). The data was analysed using One-way Analysis of Variance (ANOVA) followed by Dunnett’s- test.*P < 0.5, *P < 0.01vs Control
Diabetic Neuropathy Results:
TABLE:3 EFFECT OF POLYHERBAL 1 AND POLYHERBAL 2 TREATMENT ON NEUROPATHY MODELS
Group | Treatment | Paw Withdrawal Latency (in Sec) | Tail Flick Withdrawal Latency ( in Sec) | Hot Water Immersion Tail withdrawal latency (in sec ) | Cold Water Tail Immersion withdrawal latency (in sec) | RotarodLatency ( in sec ) |
1 | Normal Control | 12.9±0.48 | 1.71±0.10 | 4.3±0.15 | 8.4±0.20 | 262.5±15.5 |
2 | Diabetic control | 8.05±0.60 | 1.34±0.03 | 2.34±0.16 | 3.7±0.20 | 44.8±4.4 |
3 | Diabetic+ Polyherbal 1 (1ml/kg) | 14.5±0.33** | 3.19±0.16* | 4.72±0.14** | 9.9±0.29* | 199.5±21.2** |
4 | Diabetic+Polyherbal 2 (1ml/kg) | 16.6±0.42* | 2.70±0.09* | 4.29±0.15** | 12.1±0.31* | 139±9.8* |
5 | Diabetic+Metformin (120mg/kg) | 13.2±0.55** | 2.72±0.08* | 4.38±0.17** | 7.7±0.28** | 119±10.4* |
Results are expressed as Mean ± SEM (n=6). The data was analysed using One-way Analysis of Variance (ANOVA) followed by Dunnett’s- test.*P < 0.01, **P < 0.05 vs Control.
Learning and memory dysfunction results:
TABLE: 4 EFFECT OF POLYHERBAL 1 AND POLYHERBAL 2 TREATMENT ON LEARNING AND MEMORY DYSFUNCTION MODELS
Group | Treatment | Elevated Plus Maze Test | Object Recognition Test | Open Field Test | |||
Transfer latency(seconds) | Exploration (Seconds) | Numbers of squares/rearing | |||||
Central platform | Familiar object | Novel object | Closed arm | Locomotor activity | Rearing | ||
1 | Normal Control | 5.9±0.21 | 5.5±0.51 | 5.9±0.47 | 20.3±1.5 | 46.1±3.5 | 33.5±2.3 |
2 | Diabetic control | 13.5±0.90 | 2.5±0.20 | 1.7±0.45 | 50.5±12.9 | 24.3±3.02 | 15.5±1.6 |
3 | Diabetic + Polyherbal 1 (1ml/kg) | 7.4±0.60** | 5.1±0.35** | 5.1±0.25** | 19.3±2.3** | 41.8±2.2** | 30.1±4** |
4 | Diabetic +Polyherbal 2 (1ml/kg) | 8.9±0.53* | 3.9±0.31** | 6.7±0.62** | 20.1±1.7** | 37.6±2.3** | 24±2** |
5 | Diabetic + Metformin (120mg/kg) | 10.9±0.51* | 3.8±0.26* | 5.2±0.38** | 21.8±1.4** | 37±3.2** | 25.5±2.7** |
Results are expressed as Mean ± SEM (n=6). The data was analysed using One-way Analysis of Variance (ANOVA) followed by Dunnett’s- test. *P < 0.01**P < 0.05 vs Control.
TABLE 5: EFFECT OF POLYHERBAL 1 AND POLYHERBAL 2 ON BIOCHEMICAL PARAMETERS.
Grp | Treatment | CRP(mg/dl) | LDL(mg/dl) | Liver Glycogen(mg/2gm liver wt) | SGOT(mg/dl) | SGPT(mg/dl) | Triglycerides(mg/dl) | Urea(mg/dl) | Creatininemg/L |
1 | NormalControl | 0.29±0.02 | 33.6±1.9 | 2.1±0.06 | 58.3±1.8 | 49±3 | 92.1±2.4 | 36.5±1.4 | 1.05±0.04 |
2 | Diabetic control | 1.49±0.09 | 75.5±4.1 | 1.49±0.09 | 169±6.2 | 155.5±9.09 | 188.8±11.5 | 76±3 | 2.24±0.09 |
3 | Diabetic + Polyherbal 1 (1ml/kg) | 0.65±0.06* | 39.1±2.1** | 2.27±0.07** | 85.1±5.5** | 64.6±7.5** | 96.8±3.9** | 41±1.3** | 0.93±0.09** |
4 | Diabetic +Polyherbal 2 (1ml/kg) | 0.61±0.04* | 26.3±1.4** | 2.25±0.11** | 106.8±10.7* | 57.5±4.5** | 98.6±3.9** | 45.1±3.3** | 0.96±0.08** |
5 | Diabetic + Metformin (120mg/kg) | 0.79±0.05* | 32.8±2.7** | 2.07±0.06** | 114.1±7.1* | 64±6.1** | 100.3±4.2** | 47.8±3** | 1.1±0.06** |
Results are expressed as Mean ± SEM (n=6). The data was analysed using One-way Analysis of Variance (ANOVA) followed by Dunnett’s- test. *P < 0.01 and **P < 0.05 vs Control.
Effect of Polyherbal 1 and Polyherbal 2 on fasting blood glucose:
FIG.1: BLOOD GLUCOSE
Results are expressed as Mean ± SEM (n=6). The data was analysed using One-way Analysis of Variance (ANOVA) followed by Dunnett’s- test. *P < 0.01 and **P < 0.05 vs Control.
Effect of Polyherbal 1 and Polyherbal 2 treatment on Neuropathy models:
FIG:2 HOT PLATE
FIG:3 TAIL FLICK
FIG:4 ROTA ROD
Results are expressed as Mean ± SEM (n=6). The data was analysed using One-way Analysis of Variance (ANOVA) followed by Dunnett’s- test. *P < 0.01 and **P < 0.05 vs Control
Effect of Polyherbal 1 and Polyherbal 2 treatment on Learning and Memory Dysfunction Models:
FIG.5: ELEVATED PLUS MAZE
FIG:6 OPEN FIELD TEST
FIG.7: OBJECT RECOGNITION TEST
Results are expressed as Mean ± SEM (n=6). The data was analysed using One-way Analysis of Variance (ANOVA) followed by Dunnett’s- test. *P < 0.01 and **P < 0.05 vs Control
DISCUSSION: The concept of efficacy in phytotherapy is based on the mixture of substances contained in the medicinal plants and the polyherbal formulations composed of more than one herbal ingredient have specific time proven therapeutic values 8. Treatment with Polyherbal formulation 1 and 2 and Metformin lowered elevated blood glucose level, which was high in diabetic control animals. Maximum reduction in the blood glucose level was noted with Polyherbal formulation1. Thus Polyherbal formulation 1proved significant hypoglycemic activity in diabetic rats, which was comparable to the standard drug used i.e. Metformin. Polyherbal formulation 1 and 2 and Metformin significantly decreased the serum lipids level and serum enzyme levels of SGOT and SGPT. The main ingredient of these Polyherbal preparations is Syzygium cumini. In India decoction of kernels of Eugenia jambolana is used as a household remedy for diabetes it ameliorates Insulin Resistance and β-Cell Dysfunction via Modulation of PPARγ, Dyslipidemia, Oxidative Stress, and TNF-α in Type 2 Diabetic Rats 9. Effect on other biochemical parameters like LDL, Urea, Creatinine, Triglycerides and CRP was also beneficial. Table 5
Alloxan-induced diabetic model exhibits a profound hyperalgesia and motor in coordination which was evident within 2 weeks of alloxan injection and lasted for at least 4 weeks 10. Diabetic rats with autonomic neuropathy presented lower scores in cognitive tests of memory than non-diabetic subjects. (Table 4)
Neuropathic pain is the most common symptom associated with diabetic neuropathy. Alloxan injected rats had significantly higher blood glucose level, decreased body weight and the nociceptive threshold was significantly lower than non-diabetic rats in hot plate, tail flick, hot and cold water tail immersion, indicating that diabetic animals exhibit thermal hyperalgesia. In Rota rod test motor in coordination was observed in diabetic animals. Treatment with Polyherbal 1 and Polyherbal 2 restored body weight, blood glucose, along with pain threshold and motor in coordination in diabetic rats. Hyperglycemia effects locomotor activity and learning and memory also 11 12. (Table 3, 4)
PHB 2: The antioxidant effect may be due to Punica Granatum, pomegranate juice exerts significant antioxidant activity in diabetes patients without affecting the blood sugar levels. This helps reduce the oxidative stress caused by free radicals formed as a result of various metabolic processes in the body and also prevents atherosclerosis, or plaque formation in the blood vessels. Pomegranate juice may also improve insulin sensitivity and lower the risks of developing type 2 diabetes in the first place 13 14. Emblic Myrobalan also have strong free radical scavenging activity. It relieves the oxidative stress and improving glucose metabolism in diabetes and stimulates pancreas 15. Momordica Charantia juice acts against free radical mediated oxidative damage to biomolecules and membranes16. Asphaltum having Fulvic acid successfully eradicates free radical damage to pancreatic islet beta cells, a leading cause of diabetes 17 18. Inula racemosa enhances peripheral sensitivity of insulin action 19. Inula has antioxidant properties because greater availability of GSH to the cell leads to higher rate of destruction of deleterious hydrogen peroxide and lipid peroxides by glutathione peroxidase and hence, protection of vital biomolecules, nucleic acids, carbohydrates, proteins and lipids against oxidative injury associated with chemical toxicity and certain diseases 20.
The hypoglycemic effect of I racemosa could be because of increased utilization of Glucose by peripheral tissues without affecting insulin secretion, additionally because of beta blocking activity it might be sensitizing insulin receptor in the periphery. Its cortisol lowering activity along with antiperoxidative and hypoglycemic activity has been reported. I racemosa possess large number of sesquiterpene lactones and essential oils responsible for antidiabetic and antioxidant activity 21. Ricinus communis The beneficial effects is possibly due to the flavonoids present in R. communis, roots are known to possess free radical scavenging activity. The mechanism of antidiabetic activity may be its protective role in quenching free radicals and thus beneficial in survival of pancreatic beta cells 22. The B diffusa leaves are rich in alkaloids and sterols including ursolic acid, hypoxanthine-9-L-arabinofuranoside, punarnavine 1 and 2, myricyl alcohol, myristic acid and quinolizidine alkaloids.
These compounds may be responsible for the antioxidant and antidiabetic activity of B. diffusa leaves, which may be attributed to its protective action on lipid peroxidation and to the enhancing effect on cellular antioxidant defense contributing to the protection against oxidative damage in alloxanized diabetes 23. These profound effects of B. diffusa root extract against oxidative plasmid DNA damage, antioxidant and α-amylase inhibitory activity explains its extensive use in daily life and possible health benefits 24. Zinziber officinalis of PHB 2 reduces the marked rises in body weight, serum glucose, insulin, total cholesterol, LDL, triglycerides, free fatty acid, and phospholipids induced by high-fat diet significantly 25. It alleviates signs of metabolic syndrome, including decrease of blood glucose, total lipid, and an increase in total antioxidant level 26. It shows better glucose tolerance and enhanced serum insulin concentration in diabetic rats 27. Furthermore, the major pungent component in ginger, [6]-gingerol significantly decreases fasting blood glucose and improves glucose tolerance in db/db type 2 diabetic mice and loweres plasma triglyceride, total cholesterol, free fatty acid, low-density lipoprotein, and plasma insulin levels 28. Acorus calamus in diabetic rats reduces the activity of AST, ALT and ALP in plasma compared to the diabetic untreated group and consequently alleviates liver damage 29. It has insulin releasing, insulin sensitizing and alpha glucosidase inhibiting activity 30. Asparagus racemosus shows significant antidiabetic activity, antihyperlipidemic and antioxidant properties in diabetic rats 31.
Prolonged exposure to high glucose concentrations (hyperglycemia) promotes the development of microvascular complications associated with diabetes mellitus 32. Such complications affect the kidneys (nephropathy), eyes (retinopathy), heart (cardiomyopathy), nerves (neuropathy) and blood vessels 33. It is well accepted that, the high oxidative stress in diabetics considerably contributes to the complication of this disease 34. Symplocos racemosa potentiates, the pancreatic secretion of insulin from regenerated beta-cells, or its action to release bound insulin from regenerated beta cells by inhibiting ATP sensitive K+ channels like glibenclamide. It showed the presence of beta sitosterol which has antioxidant antidiabetic and antilipidemic activity 35.Woodfordia fruticosa again of PHB 2 possess potential antihyperglycemic effect by regulating glucose homeostasis and antioxidant efficacy in diabetic rats 36.
PHB 1: Has M. charantia which contains at least one ingredient with selective 11β-HSD1 inhibitory activity 37. As such, Momordica charantia increases the renewal of beta-cells in the pancreas or may permit the recovery of partially destroyed beta-cells 38, remarkably stimulates glycogen storage by the liver and improves peripheral glucose uptake 39. Punica granatum stimulates the expression of the PPAR-γ gene 40. Withania somnifera and Aloe vera are more effective in reducing oxidative damage in brain regions than the supplementation of single plant extract. The combination also lowers the blood glucose level. Memory impairment and motor dysfunction are also improved by the plant extracts supplementation 41. Chlorophytum borivilianum also has significant antidiabetic activity 42. Allium sativum decreases significantly the concentration of serum lipids, blood glucose and activities of serum enzymes like alkaline phosphatase, acid phosphatase and lactate dehydrogenase and liver glucose-6-phosphatase.
It increases significantly liver and intestinal HMG CoA reductase activity and liver hexokinase activity 43. Piper nigrum seeds are similar to insulin in having a hypoglycemic effect, they also check the antioxidant level 44. Aloe decreases oxidative load. The Aloe barbadensis also act by either directly scavenging the reactive oxygen metabolites, due to the presence of various antioxidant compounds or by increasing the synthesis of antioxidant molecule 45.
Open field test observations indicated that the impaired performance of diabetic rats is related to cognitive dysfunction rather that thygmotaxic behavior, since the number of locomotor counts and rearing of diabetic rats were decreased to non-diabetic rats. PHB 1 also prevented motor in coordination seen in diabetic neuropathy. PHB 2 is also very effective in preventing motor in coordination. The EPM test is a simple method for the evaluation of learning and memory process. Since the animals are able to remember the configuration of the open and enclosed arms, they escape from the unsafe open arm more rapidly on the second trialIt is possible to evaluate the fear motivated learning, which underlies the transfer latency procedure in this test. Shortened transfer latency on third day’s trial in rats is used as a parameter for retention or consolidation of memory. Transfer latency of Polyherbal treated rats was less comparable to normal rats showing that they are effective in memory dysfunction also. In object recognition test exploration of the animal to the novel object and familiar object is similar indicating memory impairment in diabetic rats. The current study explored the findings demonstrating that diabetes reduced learning and memory performance, whereas PHB 2 was very effective in showing positive effect in open field test shown by increased exploration of novel object than familiar object.
CONCLUSION: The roles of oxidative stress in nerve damage have been studied extensively in experimental diabetes and diabetic patients 46 However, oxidative stress also contributes to the cognitive dysfunction during hyperglycemia. Oxidative damage to the synapses in the rats cerebral cortex and hippocampus is reported to contribute to the deficit of cognitive functions. Therefore, anti-oxidants might be of use in the prevention of the neurodegeneration and cognitive dysfunctions associated with diabetes 47
Polyherbal 1 and 2 were also effective in Diabetic neuropathy maybe due to antioxidant activity. Therefore, the reversal of hyperalgesia and restoration of cognitive function was observed in diabetic rats. As diabetes is a multifactorial disease leading to several complications, and therefore demands a multiple therapeutic approach 48 49. Therefore Polyherbals were found to be very effective in Diabetes and Diabetic complications. The formulation Polyherbal 1 was found to be more efficacious as compared to Polyherbal 2. The significant antidiabetic activity of polyherbal formulations may be due to inhibition of free radical generation and subsequent tissue damage induced by alloxan or potentiation of plasma insulin effect by increasing either pancreatic secretion of insulin from existing beta cells or its release from bound form as indicated by significant improvement in glucose and protein level because insulin inhibit gluconeogenesis from protein.
FUTURE PROSPECTS: Natural drugs from traditional Indian medicine are gaining popularity because of several advantages such as fewer side-effects, better patient tolerance, relatively less expensive and acceptance due to a long history of use. The more important cause is that natural products, especially herbal medicines provide rational means for the treatment of many diseases that are obstinate and incurable in other systems of medicine.50
CONFLICT OF INTEREST STATEMENT: We declare that we have no conflict of interest.
REFERENCES:
- Goodman and Gilman’s, The Pharmacological basis of therapeutics, 11th edition.
- McGraw-Hill, Medical Publishing Division, 2006, 933.
- Herbal medicine for human health/Ranjit Roy Chaudhury3.Khan Cr. and Shechter Y. (1991) Oral hypoglycemic agents and the pharmacology of the endocrine pancreas. In: Theodore, W.R., Alan, S.N., Taylor, P. and Gilman, Ag, Eds., Goodman and Gilman’s the Pharmacological Basis of Therapeutics, 8th Edition, McGraw-Hill, New York.
- Debora Cristina Damasceno, Gustavo Tadeu Volpato, Iracema de Mattos Paranhos Calderon, Marilza Vieira Cunha Rudge. Oxidative stress and diabetes in pregnant rats. Animal Reproduction Science. Volume 72, Issues 3–4, 15 August 2002, Pages 235–244.
- Nazer J, Ramírez R. Congenital malformations in the offspring of diabetic mothers (PMID: 11349494). Revista Medica de Chile. 2000, 128(9):1045-1052.
- Anushka Patel. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the advance trial): a randomised controlled trial. The Lancet. Volume 370, Issue 9590, 8–14 September 2007, Pages 829–840.
- Ahren B, Rajab A, Buttcher G, Sundler F and Dunning B.E. Presence of Glanin in human pancreatic nerves and inhibition of insulin secretion from isolated human islets. Cell and Tissue Res,264: 263-267
- Latha V, Rajesh M G and Latha M S. Hepatoprotective Effect of Ayurvedic medicine. Indian Drugs.1993 36:p 470
- Ashok kumar Sharma, saurabh bharti, Rajiv Kumar, Bhaskar Krishnamurthy, Jagriti Bhatis et al Syzygium cumini ameliorates Insulin Resistance and β-Cell Dysfunction via Modulation of PPARγ, Dyslipidemia, Oxidative Stress, and TNF-α in Type 2 Diabetic Rats. Journal of Pharmacological Sciences. Vol 119,No 3 p 205-213. Journal of Pharmacological Sciences
- Bach-Rojecky L, Salkovic-Petrisic M, Lackovic Z. Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection. Eur J Pharmacol. 2010 May 10; 633.
- John D Mayer, Maria DiPaola, Peter Salovey. Journal of personality assessment.1990.
- Alyson Fox, Christopher Eastwood, Clive Gentry, Donald Manning, Laszlo Urban. Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Volume 81, Issue 3, 1 June 1999, Pages 307–316.
- Mira Rosenblat, Tony Hayek, Michael Aviram. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis. Volume 187, Issue 2, August 2006, Pages 363–371.
- Wasseem Rock, Mira Rosenblat, Rachel Miller-Lotan, Andrew P. Levy, Mazen Elias and Michael Aviram. Internal Medicine Consumption of Wonderful Variety Pomegranate Juice and Extract by Diabetic Patients Increases Paraoxonase 1 Association with High-Density Lipoprotein and Stimulates Its Catalytic Activities. Agric. Food Chem. 2008, 56 (18), pp 8704–8713.
- P. Rao, N. Sakaguchi, L.R. Juneja, E. Wada, and T. Yokozawa. Amla (Emblica officinalis Gaertn.) Extracts Reduce Oxidative Stress in Streptozotocin-Induced Diabetic Rats Journal of Medicinal Food. Fall 2005, 8(3): 362-368.
- Dhanasekar Sathis Sathishsekar and Sorimuthu Subramanian. Antioxidant properties of Momordica Charantia (bitter gourd) seeds on Streptozotocin induced diabetic rats. Asia Pac J Clin Nutr. 2005; 14(2):153-158.
- Trivedi N.A, Mazumdar B, Bhatt J D, Hemavathi K G. Effect of shilajit on blood glucose and lipid profile in alloxan induced diabetic rats. Indian Journal of Pharmacology. Nov-2004. 36(6).
- Salil K. Bhattacharya. Shilajit attenuates streptozotocin induced diabetes mellitus and decrease in pancreatic islet superoxide dismutase activity in rats. Phytotherapy Research. February 1995.Volume 9, Issue 1, pages 41–44.
- P. Chaturvedi, S. Shukla, P. Tripathi, S. Chaurasia, S.K. Singh and Y.B. Tripathi .Comparative study of Inula Racemosa and Saussurea Lappa on the glucose level in Albino rats. Ancient Science of Life, Vol No. XV No.1 July 1995, Pages 62-70.
- S Salil, A Bhupinder, A Basheer.Antioxidant Properties Of Inula Racemosa, A Traditional Herbal Medicine. The Internet Journal of Pharmacology. 2012 Volume 10 Number 1.
- B. Ajani, H. P. Patel, G. B. Shah, S. R. Acharya S. K. Shah. Evaluation of Antidiabetic effect of Methanolic Extract of Inula racemosa root in rats. Pharmacologyonline 3. 2009. 118-129
- Poonam Shokeen, Prachi Anand, Y. Krishna Murali, Vibha Tandon. Antidiabetic activity of 50% ethanolic extract of Ricinus communis and its purified fractions. Food and Chemical Toxicology 2008 3458–3466.
- M Amarnath Satheesh & L Pari. Antioxidant effect of Boerhavia diffusa in tissues of alloxan induced diabetic rats. Indian Journal of Experimental Biology. Vol. 42, October 2004, pp. 989-992.
- Akhter, A. Hashim, M.S. Khan, S. Ahmad, D. Iqbal, A.K. Srivastava, M.H. Siddiqui. Antioxidant, α-amylase inhibitory and oxidative DNA damage protective property of Boerhaavia diffusa (Linn.) root. South African Journal of Botany.Volume 88, September 2013, Pages 265–272
- Nammi S, Sreemantula S, Roufogalis B D. Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic and Clinical Pharmacology and Toxicology. 2009;104(5):366–373.
- Madkor H R, Mansour S W, Ramadan G. Modulatory effects of garlic, ginger, turmeric and their mixture on hyperglycaemia, dyslipidaemia and oxidative stress in streptozotocin-nicotinamide diabetic rats. British Journal of Nutrition. 2010; 105(08):1210–1217.
- Islam M S, Choi H. Comparative effects of dietary ginger (Zingiber officinale) and garlic (Allium sativum) investigated in a type 2 diabetes model of rats. Journal of Medicinal Food.2008; 11(1):152–159.
- Singh A B, Akanksha, Singh N, Maurya R, Srivastava A K. Anti-hyperglycaemic, lipid lowering and anti-oxidant properties of [6]-gingerol in db/db mice. International Journal of Medicine and Medical Sciences.2009; 1(12):536–544.
- David Hansi Prisilla, Rangachari Balamurugan, Harshit R Shah. Antidiabetic activity of methanol extract of Acorus calamus in STZ induced diabetic rats. Asian Pacific Journal of Tropical Biomedicine. 2012. S941-S946.
- Mei-mei Sia, Jian-shu Loua, Chang-Xin Zhoub, Juan-Na Shena, Hong-Hai Wua, Bo Yanga, Qiao-Jun Hea, Hao-Shu Wua. Insulin releasing and alpha-glucosidase inhibitory activity of ethyl acetate fraction of Acorus calamus in vitro and in vivo. Journal of Ethnopharmacology 128 .2010.154–159.
- Ramachandran Vadivelan, Mandal Dipanjan, Payyavala Umasankar, Sangai Palaniswami Dhanabal, Muthureddy Nataraj Satishkumar, Shanish Antony and Kannan Elango. Hypoglycemic, antioxidant and hypolipidemic activity of Asparagus racemosus on streptozotocin-induced diabetic in rats. Advances in Applied Science Research, 2011, 2 (3): 179-185.
- The Diabetes Control and Complications Trial Research Group, 1993; UK Prospective Diabetes Study (UKPDS) Group, 1998.
- Michael Brownlee. Biochemistry and molecular cell biology of diabetic complications. Nature 414. December 2001. 813-820.
- John W. Baynes and Suzanne R. Thorpe. Role of Oxidative Stress in Diabetic Complications A New Perspective on an Old Paradigm. Diabetes, January 1999. VOL. 48.1-9.
- Yoshida Y, Niki E, Noguchi N. Comparative study on the action of tocopherols and tocotrienols as antioxidant: chemical and physical effects. Chem Phys Lipids. 2003 Mar; 123(1):63-75.
- Verma Neeraj, Amresh G, Sahu P K, Rao Ch V, Singh Anil Pratap. Antihyperglycemic activity of Woodfordia fruticosa (Kurz) flowers extracts in glucose metabolism and lipid peroxidation in streptozotocin-induced diabetic rats. Indian Journal of Experimental Biology. 2012 May; 50(5): 351-358.
- Andreas Blum, Christine Loerz, Hans-Joerg Martin, Claudia A. Staab-Weijnitz, Edmund Maser Momordica charantia extract, a herbal remedy for type 2 diabetes, contains a specific 11β-hydroxysteroid dehydrogenase type 1 inhibitor. The Journal of Steroid Biochemistry and Molecular Biology. Volume 128, Issues 1–2,January 2012, Pages 51-55
- Ahmed E, Adeghate K, Sharma D.J, Pallot J Singh. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Research and Clinical Practice. Volume 40, Issue 3, June 1998, Pages 145–151.
- Welihinda and E.H. Karunanayake. Extra-pancreatic effects of Momordica charantia in rats. Journal of Ethnopharmacology. Volume 17, Issue 3, September 1986, Pages 247–255.
- Tom H.W. Huang, Gang Peng, Bhavani P. Kota, George Q. Li, Johji Yamahara, Basil D. Roufogalis, Yuhao Li. Anti-diabetic action of Punica granatum flower extract: Activation of PPAR-γ and identification of an active component. Toxicology and Applied Pharmacology.Volume 207, Issue 2, 1 September 2005, Pages 160–169.
- S Parihar, Madhulika Chaudhary,Rajani Shetty,Taruna Hemnani. Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania somnifera and Aloe vera. Journal of Clinical Neuroscience. Volume 11, Issue 4, May 2004, Pages 397–402.
- Sreevidya Narasimhan, Raghavan Govindarajan, Vijayakumar Madhavan , M. Thakur , V. K. Dixit, Shanta Mehrotra , K. P. Madhusudanan. Action of (2→1) Fructo-oligopolysaccharide Fraction of Chlorophytum borivilianum against Streptozotocin-Induced Oxidative Stress. Planta Med 2006; 72(15): 1421-1424.
- C G Sheela, K T Augusti -Antidiabetic effects of S-allyl cysteine sulphoxide isolated from garlic Allium sativum Linn. Indian journal of experimental biology.1995 May; 33(5):337-41.
- Kaleem, Sheema H. Sarmad and B. Bano. Protective effects of piper nigrum and vinca rosea in alloxan induced diabetic rats. Indian J Physiol Pharmacol 2005; 49 (1) : 65–71
- Harrison U. Nwanjo. Antioxidant activity of the exudate from Aloe barbadensis leaves in diabetic rats. Biokemistri. December 2006. 18(2):77-81.
- Pravinkumar Bhutada,Yogita Mundhada, Kuldeep Bansod, Chetan Bhutada, Santosh Tawari, Pankaj Dixit, Dharmendra Mundhada. Ameliorative effect of quercetin on memory dysfunction in streptozotocin-induced diabetic rats. Neurobiology of Learning and Memory Volume 94, Issue 3, October 2010, Pages 293–302.
- A. Pathade, Y.S. Ahire, V.A. Bairagi and D.R. Abhang. Antioxidants Therapy in Cognitive Dysfunction Associated with Diabetes Mellitus: An Overview. Research Journal of Pharmacology and Pharmacodynamics. March –April, 2011 Volume 03, Issue 02.
- Sunila Vasi and Anoop Austin. Effect of Herbal Hypoglycemics on Oxidative Stress and Antioxidant Status in Diabetic Rats.The Open Diabetes Journal, 2009, 2, 48-52.
- Ashok K. Tiwari and J. Madhusudana Rao Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects. Current Science, 10 July 2002.Vol. 83, No 1.
- Om Prakash, Rajesh Kumar, Ritika Srivastava, Pragya Tripathi, Shradha Mishra, Ajeet. Plants Explored with Anti-diabetic Properties: A Review. American Journal of Pharmacological Sciences. 3, No. 3, 2015, pp 55-66
How to cite this article:
Shahana S, Shabana S, Hundekari G, Mohd Saifuddin, Nikalje AG and Yousuf SA: Comparative Study of Hypoglycemic Effects and Antioxidant Potential of Polyherbal Formulation in Alloxan Induced Diabetic Rats an Alternative Therapeutic Agent for Diabetes Management. Int J Pharm Sci Res 2015; 6(10): 4381-90.doi: 10.13040/IJPSR.0975-8232.6(10).4381-90.
All © 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
34
4381-90
580
1471
English
Ijpsr
S. Shahana *, S. Shabana, G. Hundekari, Md. Saifuddin, A.G. Nikalje and S. Abdulla Yousuf
Kamala Nehru Polytechnic Pharmacy, Aurangabad, Maharashtra, India
shahanakalim@gmail.com
17 November, 2014
14 July, 2015
22 September, 2015
10.13040/IJPSR.0975-8232.6(10).4381-90
01 October, 2015